首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1740858

心臟映射市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Cardiac Mapping Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年04月25日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年，全球心臟測繪市場規模達25億美元，預計年複合成長率為7.6%，到2034年將達52億美元。推動這一成長軌跡的因素有很多，包括電生理學(EP)手術的激增、優惠的報銷政策以及全球心血管疾病發病率的上升。技術進步和醫療基礎設施的改善進一步推動了對創新心臟測繪系統的需求。 EP實驗室數量的持續成長和心臟消融手術數量的增加直接促進了這些系統的普及。由於EP手術創傷小且療效持久，醫療保健提供者正在將心臟測繪作為心律管理策略的核心組成部分。

擁有先進醫療保健體系的國家已將心臟測繪納入標準化報銷結構，使醫院能夠以經濟高效的方式整合這些系統。同時，新興市場由於醫療保健覆蓋率的擴大和基礎設施投資的增加而展現出良好的前景。因此，這些地區為製造商和供應商提供了尚未開發的機會。隨著電生理實驗室擴大採用測繪解決方案進行精準干預，已開發經濟體和發展中經濟體的前景仍然強勁。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	25億美元
預測值	52億美元
複合年成長率	7.6%

按類型分類，市場分為接觸式心臟標測系統和非接觸式心臟標測系統。接觸式心臟標測系統領域在2024年佔據主導地位，估值超過19億美元。此領域表現強勁，尤其體現在診斷和管理複雜心律不整（如心房撲動、心房顫動和室性心動過速）。這些系統使用配備電極的專用導管，可直接接觸心臟組織，從而即時捕捉高解析度電訊號。這種精細的標測使電生理學家能夠準確檢測不規則電活動，並以更高的精度指導治療。

根據適應症，心臟測繪市場涵蓋心房顫動、心房撲動及其他相關疾病。心房顫動在2024年佔據超過58.1%的市場佔有率，佔據市場主導地位。這種主導地位可能與全球範圍內該疾病發病率的上升有關，尤其是在人口老化以及高血壓、糖尿病和肥胖等相關併發症日益普遍的情況下。心臟測繪已成為心房顫動診斷和治療的重要工具，它能夠提供更有針對性的治療方案，從而改善預後。心律不整病例的日益複雜性也凸顯了詳細測繪對於提高療效和降低復發率的重要性。

就最終用戶而言，市場分為醫院、心臟中心和其他護理機構。醫院在2024年成為表現最佳的細分市場，預計2034年其市場價值將達到35億美元。醫院的主導地位歸功於其擁有訓練有素的專業人員、整合的電生理實驗室以及先進的診斷和治療技術。這些機構是治療複雜心律不整的主要樞紐，提供住院和急診護理，這使其成為心臟標測系統的理想環境。醫院正在廣泛部署3D電解剖標測平台和高密度標測導管，以支援先進的消融手術。這種整合支援即時高清成像，從而以更高的精度指導干預。

此外，三級醫療機構微創手術的穩定成長以及發展中國家公立和私立醫院基礎設施的不斷擴展，正在創造新的機會。這些醫療中心的心律不整轉診量也不斷增加，並受益於更有利的消融治療報銷框架。

從地區來看，北美市場處於領先地位，其中美國在2024年的收入為9.726億美元。預計2025年至2034年期間，美國市場的複合年成長率將達到6.5%。美國市場表現強勁，得益於其心律不整的高發病率、密集的醫療機構網路以及電生理檢查（EP）程序的高採用率。佔據較大市場佔有率的主要參與者正在積極開發更有效率、更方便用戶使用的映射系統，改善工作流程，並專注於以患者為中心的創新。這些公司也大力投資專業培訓，並在成本敏感市場拓展其技術的普及範圍，以確保其技術能得到更廣泛的應用。

產業生態系統分析
產業衝擊力
- 成長動力
  - 心血管疾病發生率高
  - 提高對心血管疾病治療方案的認知
  - 政府對研究和資助的優惠政策
  - 產品技術進步
- 產業陷阱與挑戰
  - 心臟測繪系統成本高昂
  - 缺乏熟練且經驗豐富的電生理學家
成長潛力分析
監管格局
川普政府關稅
- 對貿易的影響
  - 貿易量中斷
  - 報復措施
- 對產業的影響
  - 供應方影響（原料）
    - 主要材料價格波動
    - 供應鏈重組
    - 生產成本影響
  - 需求面影響（售價）
    - 價格傳導至終端市場
    - 市佔率動態
    - 消費者反應模式
- 受影響的主要公司
- 策略產業反應
  - 供應鏈重組
  - 定價和產品策略
  - 政策參與
- 展望與未來考慮
報銷場景
技術格局
波特的分析
差距分析
PESTEL分析

第4章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
公司市佔率分析
競爭定位矩陣
策略儀表板

第5章：市場估計與預測：按產品，2021 - 2034 年

主要趨勢
測繪導管
地圖系統

第6章：市場估計與預測：按類型，2021 - 2034 年

主要趨勢
接觸式心臟測繪系統
非接觸式心臟測繪系統

第7章：市場估計與預測：按適應症，2021 - 2034 年

主要趨勢
心房震顫
心房撲動
其他適應症

第8章：市場估計與預測：依最終用途，2021 - 2034 年

主要趨勢
醫院
心臟中心
其他最終用途

第9章：市場估計與預測：按地區，2021 - 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第10章：公司簡介

Abbott Laboratories
Acutus Medical
APN Health
BioSig Technologies
Biotronik
Boston Scientific
Catheter Precision
Coremap
Epmap-System
Johnson & Johnson
Kardium
Koninklijke Philips
Lepu Medical
Medtronic
MicroPort Scientific

簡介目錄

Product Code: 13628

The Global Cardiac Mapping Market was valued at USD 2.5 billion in 2024 and is estimated to grow at a CAGR of 7.6% to reach USD 5.2 billion by 2034. Several factors are driving this growth trajectory, including the surge in electrophysiology (EP) procedures, favorable reimbursement policies, and an increasing prevalence of cardiovascular conditions worldwide. Technological advancements and improved healthcare infrastructure are further pushing demand for innovative cardiac mapping systems. A consistent rise in EP labs and the volume of cardiac ablation procedures has directly contributed to the increased adoption of these systems. Because EP procedures are minimally invasive and offer long-term results, healthcare providers are making cardiac mapping a core component of cardiac rhythm management strategies.

Countries with advanced healthcare systems have incorporated cardiac mapping into standardized reimbursement structures, making it cost-effective for hospitals to integrate these systems. At the same time, emerging markets are showing promise due to expanding healthcare access and infrastructure investments. As a result, these regions present untapped opportunities for manufacturers and providers. With EP labs increasingly adopting mapping solutions for precision-based interventions, the outlook remains strong across both developed and developing economies.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$2.5 Billion
Forecast Value	$5.2 Billion
CAGR	7.6%

By type, the market is split into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment captured a dominant position in 2024, with a valuation exceeding USD 1.9 billion. This segment is showing robust performance, particularly because of its role in diagnosing and managing complex arrhythmias like atrial flutter, atrial fibrillation, and ventricular tachycardia. These systems use specialized catheters equipped with electrodes that make direct contact with cardiac tissue, allowing for real-time capture of high-resolution electrical signals. This detailed mapping enables electrophysiologists to accurately detect irregular electrical activity and guide treatment with enhanced precision.

On the basis of indication, the cardiac mapping market includes atrial fibrillation, atrial flutter, and other related conditions. Atrial fibrillation led the market with a commanding share of over 58.1% in 2024. This dominance can be linked to the growing incidence of the condition globally, particularly as aging populations and related comorbidities such as hypertension, diabetes, and obesity become more common. Cardiac mapping has become an essential tool in the diagnosis and treatment of atrial fibrillation, offering a more targeted approach that supports improved outcomes. The increasing complexity of arrhythmia cases has also highlighted the importance of detailed mapping to enhance treatment efficacy and reduce recurrence rates.

In terms of end users, the market is divided into hospitals, cardiac centers, and other care facilities. Hospitals emerged as the top-performing segment in 2024 and are projected to reach a market value of USD 3.5 billion by 2034. Their dominance is attributed to the presence of trained professionals, integrated EP labs, and access to advanced diagnostic and therapeutic technologies. These facilities are the primary hubs for treating complex arrhythmias, offering both inpatient and emergency care, which makes them an ideal environment for cardiac mapping systems. Hospitals are widely deploying 3D electroanatomical mapping platforms and high-density mapping catheters to support advanced ablation procedures. This integration supports real-time, high-definition imaging that guides interventions with improved accuracy.

Additionally, the steady growth of minimally invasive procedures in tertiary care facilities and expanded infrastructure in public and private hospitals across developing nations are creating new opportunities. These healthcare centers are also receiving increased referrals for arrhythmia services and benefiting from more supportive reimbursement frameworks for ablation therapies.

Regionally, North America leads the market, with the United States generating USD 972.6 million in revenue in 2024. The U.S. market is poised to grow at a CAGR of 6.5% from 2025 to 2034. The country's strong performance is due to the high prevalence of cardiac arrhythmias, a dense network of healthcare institutions, and a high rate of adoption of EP procedures. Major players with significant market share are actively developing more efficient and user-friendly mapping systems, improving workflows, and focusing on patient-centered innovation. These companies are also heavily investing in professional training and expanding access to their technologies in cost-sensitive markets to ensure broader adoption.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 High incidence of cardiovascular diseases
  - 3.2.1.2 Rising awareness about the treatment options for cardiovascular diseases
  - 3.2.1.3 Favourable government policies for research and funding
  - 3.2.1.4 Technological advancements in the products
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of the cardiac mapping systems
  - 3.2.2.2 Lack of skilled and experienced electrophysiologists
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trump administration tariffs
- 3.5.1 Impact on trade
  - 3.5.1.1 Trade volume disruptions
  - 3.5.1.2 Retaliatory measures
- 3.5.2 Impact on the Industry
  - 3.5.2.1 Supply-side impact (raw materials)
    - 3.5.2.1.1 Price volatility in key materials
    - 3.5.2.1.2 Supply chain restructuring
    - 3.5.2.1.3 Production cost implications
  - 3.5.2.2 Demand-side impact (selling price)
    - 3.5.2.2.1 Price transmission to end markets
    - 3.5.2.2.2 Market share dynamics
    - 3.5.2.2.3 Consumer response patterns
- 3.5.3 Key companies impacted
- 3.5.4 Strategic industry responses
  - 3.5.4.1 Supply chain reconfiguration
  - 3.5.4.2 Pricing and product strategies
  - 3.5.4.3 Policy engagement
- 3.5.5 Outlook and future considerations
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Porter's analysis
3.9 GAP analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Company market share analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Mapping catheters
5.3 Mapping systems

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Contact cardiac mapping systems
6.3 Non-contact cardiac mapping systems

Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 Atrial fibrillation
7.3 Atrial flutter
7.4 Other indications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Cardiac centers
8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE